TFToshinari Fujimoto

Toshinari Fujimoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Toshinari Fujimoto has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Kenji Matsui

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    4 shared publications
  • Shuichiro Yamanaka

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    4 shared publications
  • Takashi Yokoo

    Division of Nephrology and Hypertension, Department of Internal Medicine, Jikei University School of medicine, Tokyo, Japan

    4 shared publications
  • Eiji Kobayashi

    Division of Basic Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi 180-8602, Tokyo, Japan

    3 shared publications
  • Kei Matsumoto

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    3 shared publications
  • Susumu Tajiri

    Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan

    3 shared publications

Latest Publications

  • Open Access

    Caspase 9-induced apoptosis enables efficient fetal cell ablation and disease modeling

    by Kenji Matsui, Masahito Watanabe, Shutaro Yamamoto, Shiho Kawagoe, Takumi Ikeda, Hinari Ohashi, Takafumi Kuroda, Nagisa Koda, Keita Morimoto, Yoshitaka Kinoshita, et al.

    Fetal cell ablation models are crucial for studying congenital diseases, organ regeneration, and xenotransplantation. However, conventional knockout models offer limited control over disease severity, while conditional ablation models often require fetus-harming inducers. In the present study, we demonstrate that the inducible caspase 9 system enables precise targeting of fetal nephron progenitor cells in mice through the intrinsic apoptotic pathway. Using a safe, placenta-permeable inducer, this system facilitates specific, rapid, and efficient cell ablation. The system’s temporal control allows precise adjustment of disease severity, generating reproducible models ranging from congenital kidney deficiency to severe chronic kidney disease. Cells with low expression levels of inducible caspase 9 and those in solid organs are less susceptible to apoptosis. However, this limitation can be overcome by inhibiting the X-linked inhibitor of apoptosis protein, thereby expanding the system’s applicability. Additionally, this model provides a developmental environment suitable for chimeric kidney regeneration. This system advances understanding of induced cell death mechanisms, enhances pathological research tools, and supports therapeutic development in kidney disease and xenotransplantation applications.


  • Open Access

    Fetal-to-fetal kidney transplantation in utero

    by Keita Morimoto, Shuichiro Yamanaka, Kenji Matsui, Yoshitaka Kinoshita, Yuka Inage, Shutaro Yamamoto, Nagisa Koda, Naoto Matsumoto, Yatsumu Saito, Tsuyoshi Takamura, et al.

    Potter sequence consists of various symptoms associated with renal dysplasia. For bilateral renal agenesis, there is no hope of survival. As a novel therapeutic approach for Potter sequence, we develop a unique approach of “transplantation of fetal kidneys from a different species during the fetal stage.” In this study, we first validate the approach using allogeneic transplantation. Fetal kidneys with bladders from green fluorescent protein-expressing rats (embryonic day 14.0–16.5) are subcutaneously transplanted into allogeneic rat fetuses in utero (embryonic day 18.0–18.5). After birth, the transplanted fetal kidneys are confirmed to have urine production capability. Furthermore, long-term (up to 150 days) urine production is sustained. Next, we perform xenotransplantation. The transplantation of mouse fetal kidneys into rat fetuses in utero leads to the maturation of renal tissue structures. We demonstrate organ transplantation into in utero fetuses using fetal kidneys as donor organs for fetal therapy.


  • Evaluation of the ability of human induced nephron progenitor cells to form chimeric renal organoids using mouse embryonic renal progenitor cells

    by Naoto Matsumoto, Shuichiro Yamanaka, Keita Morimoto, Kenji Matsui, Sandy Nishimura, Yoshitaka Kinoshita, Yuka Inage, Koki Fujimori, Takao Kuroda, Yatsumu Saito, et al.


  • Open Access

    Techniques of orthotopic renal transplantation. II. Size-matched porcine grafts in monkey recipients

    by Tsuyoshi Takamura, Hiroshi Sasaki, Haruyuki Hirayama, Akihiko Kiyoshi, Makoto Inoue, Kenji Matsui, Naoto Matsumoto, Yatsumu Saito, Toshinari Fujimoto, Susumu Tajiri, et al.

    As a classical xenotransplantation model, porcine kidneys have been transplanted into the lower abdomen of non-human primates. However, we have improved upon this model by using size-matched grafting in the orthotopic position. The beneficial aspects and surgical details of our method are reported herein. Donors were two newborn pigs (weighting 5 to 6 kg) and recipients were two cynomolgus monkeys (weighting, approximately, 7 kg). After bilateral nephrectomy, kidneys were cold-transported in Euro-Collins solution. The porcine kidney was transplanted to the site of a left nephrectomy and fixed to the peritoneum. Kidneys transplanted to the lower abdomen by the conventional method were more susceptible to torsion of the renal vein (two cases). In contrast, early-stage blood flow insufficiency did not occur in orthotopic transplants of theleft kidney. Size-matched porcine-primate renal grafting using our method of transplanting tothe natural position of the kidneys contributes to stable post-transplant blood flow to the kidney.